本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

529.09
+5.831.11%
盤後529.090.00000.00%19:30 EDT
成交量:29.85萬
成交額:1.57億
市值:121.98億
市盈率:-37.22
高:529.93
開:523.00
低:517.45
收:523.26
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:1.34
換手率:2.17%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:23.29
市盈率(LYR):-41.17

資料載入中...

2020/08/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/18

重要事件披露

8-K - Current report
2020/06/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

重要事件披露

Current report, items 2.02 and 9.01
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/26

重要事件披露

Current report, items 2.02 and 9.01
2020/02/26

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/28

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/12

重要事件披露

Current report, items 1.01 and 9.01
2019/12/10

重要事件披露

Current report, item 8.01
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/07

重要事件披露

Current report, items 2.02 and 9.01